American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

NEOGENOMICS INC (NEO)

$16.59 +1.22% NASDAQ: NEO · 15-min delayed

FORT MYERS, Florida
Public · NASDAQ: NEO
2,500 employees

Visit website Follow

$1.8BMarket cap

$131.2MRevenue · FY2018

-$108.0MNet income

2,500Employees

NEONASDAQ

1996IPO

About NEOGENOMICS INC

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: NEO
Employees: 2,500
IPO date: Jan 25, 1996
Headquarters: 9490 NEOGENOMICS WAY
FORT MYERS, Florida 33912
Phone: (239) 768-0600
Industry: Professional Services
Website: Visit site

Incorporation record

Incorporated in: NV, United States
Registered office: Las Vegas, US
Legal entity ID: 254900KXWYZIKXNFT521

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: NEO Nasdaq
SEC CIK: 1077183
LEI: 254900KXWYZIKXNFT521
EIN: 742897368
SIC: 8734 SERVICES-TESTING LABORATORIES

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Neogenomics Inc’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/neogenomics-inc/"><img src="https://americancompanies.com/badge/neogenomics-inc.svg" alt="Neogenomics Inc — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow NEOGENOMICS INC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2018: $131.2M
Net income: -$108.0M
Total assets: $1.4B
Market cap: $1.8B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: NEO

$16.59 +1.22%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$7.19 $19.91

52-week range

Market cap: $1.8B
Shares outstanding: 109.0M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jan 25, 1996

Neogenomics Inc (NEO) Stock Price

Reported a net loss of $108.0M in FY2018.
Trading 17% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review NEOGENOMICS INC.

Write a review

Newsroom

News about NEOGENOMICS INC

Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)? Zacks Investment Research · 2026-09-14 · neutral State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption GlobeNewswire Inc. · 2026-08-25 · positive 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Investing.com · 2025-06-25 · neutral It's Not Too Late to Jump on These Under-the-Radar Momentum Plays Investing.com · 2025-05-06 · neutral Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide GlobeNewswire Inc. · 2025-04-08 · positive Not Just a DEX: How Pineapple’s Mystery Marketing is Changing the Game GlobeNewswire Inc. · 2025-02-17 · neutral

News & sentiment via Polygon.io

FAQ

Neogenomics Inc: frequently asked questions

Is Neogenomics Inc an American company?

Neogenomics Inc is a US-based company headquartered in Fort Myers, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Neogenomics Inc headquartered?

Neogenomics Inc is headquartered in Fort Myers, Florida, United States.

Is Neogenomics Inc publicly traded?

Yes — Neogenomics Inc is a publicly traded company. Its stock trades under the ticker symbol NEO on the NASDAQ.

What does Neogenomics Inc do?

Neogenomics Inc is an American Professional Services company in the Business & Financial Services sector.

Explore